Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)

Background: The considerable prevalence and worse outcomes of asthma-COPD overlap (ACO) in COPD have been reported, and optimal introduction of ICS is essential for ACO. However, diagnostic criteria for ACO consist of multiple laboratory tests, which is challenging during this COVID-19 era. The purp...

Full description

Bibliographic Details
Main Authors: Yuki Suzuki, Hiroyuki Nagase, Hikaru Toyota, Sho Ohyatsu, Konomi Kobayashi, Yuri Takeshita, Yuuki Uehara, Saya Hattori, Mana Ishizuka, Hirokazu Sakasegawa, Michio Kuramochi, Tadashi Kohyama, Naoya Sugimoto
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893023000059
_version_ 1797795275877646336
author Yuki Suzuki
Hiroyuki Nagase
Hikaru Toyota
Sho Ohyatsu
Konomi Kobayashi
Yuri Takeshita
Yuuki Uehara
Saya Hattori
Mana Ishizuka
Hirokazu Sakasegawa
Michio Kuramochi
Tadashi Kohyama
Naoya Sugimoto
author_facet Yuki Suzuki
Hiroyuki Nagase
Hikaru Toyota
Sho Ohyatsu
Konomi Kobayashi
Yuri Takeshita
Yuuki Uehara
Saya Hattori
Mana Ishizuka
Hirokazu Sakasegawa
Michio Kuramochi
Tadashi Kohyama
Naoya Sugimoto
author_sort Yuki Suzuki
collection DOAJ
description Background: The considerable prevalence and worse outcomes of asthma-COPD overlap (ACO) in COPD have been reported, and optimal introduction of ICS is essential for ACO. However, diagnostic criteria for ACO consist of multiple laboratory tests, which is challenging during this COVID-19 era. The purpose of this study was to create a simple questionnaire to diagnose ACO in patients with COPD. Methods: Among 100 COPD patients, 53 were diagnosed with ACO based on the Japanese Respiratory Society Guidelines for ACO. Firstly, 10 candidate questionnaire items were generated and further selected by a logistic regression model. An integer-based scoring system was generated based on the scaled estimates of items. Results: Five items, namely a history of asthma, wheezing, dyspnea at rest, nocturnal awakening, and weather- or season-dependent symptoms, contributed significantly to the diagnosis of ACO in COPD. History of asthma was related to FeNO >35 ppb. Two points were assigned to history of asthma and 1 point to other items in the ACO screening questionnaire (ACO-Q), and the area under the receiver operating characteristic curve was 0.883 (95% CI: 0.806–0.933). The best cutoff point was 1 point, and the positive predictive value was 100% at a cutoff of 3 points or higher. The result was reproducible in the validation cohort of 53 patients with COPD. Conclusions: A simple questionnaire, ACO-Q, was developed. Patients with scores ≥3 could be reasonably recommended to be treated as ACO, and additional laboratory testing would be recommended for patients with 1 and 2 points.
first_indexed 2024-03-13T03:15:29Z
format Article
id doaj.art-dba84fd8f7e74111971958f2572e5245
institution Directory Open Access Journal
issn 1323-8930
language English
last_indexed 2024-03-13T03:15:29Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series Allergology International
spelling doaj.art-dba84fd8f7e74111971958f2572e52452023-06-26T04:13:38ZengElsevierAllergology International1323-89302023-07-01723394401Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)Yuki Suzuki0Hiroyuki Nagase1Hikaru Toyota2Sho Ohyatsu3Konomi Kobayashi4Yuri Takeshita5Yuuki Uehara6Saya Hattori7Mana Ishizuka8Hirokazu Sakasegawa9Michio Kuramochi10Tadashi Kohyama11Naoya Sugimoto12Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan; Corresponding author. Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan.Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDepartment of Internal Medicine, Teikyo University Mizonokuchi Hospital, Kanagawa, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanDepartment of Internal Medicine, Teikyo University Mizonokuchi Hospital, Kanagawa, JapanDivision of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanBackground: The considerable prevalence and worse outcomes of asthma-COPD overlap (ACO) in COPD have been reported, and optimal introduction of ICS is essential for ACO. However, diagnostic criteria for ACO consist of multiple laboratory tests, which is challenging during this COVID-19 era. The purpose of this study was to create a simple questionnaire to diagnose ACO in patients with COPD. Methods: Among 100 COPD patients, 53 were diagnosed with ACO based on the Japanese Respiratory Society Guidelines for ACO. Firstly, 10 candidate questionnaire items were generated and further selected by a logistic regression model. An integer-based scoring system was generated based on the scaled estimates of items. Results: Five items, namely a history of asthma, wheezing, dyspnea at rest, nocturnal awakening, and weather- or season-dependent symptoms, contributed significantly to the diagnosis of ACO in COPD. History of asthma was related to FeNO >35 ppb. Two points were assigned to history of asthma and 1 point to other items in the ACO screening questionnaire (ACO-Q), and the area under the receiver operating characteristic curve was 0.883 (95% CI: 0.806–0.933). The best cutoff point was 1 point, and the positive predictive value was 100% at a cutoff of 3 points or higher. The result was reproducible in the validation cohort of 53 patients with COPD. Conclusions: A simple questionnaire, ACO-Q, was developed. Patients with scores ≥3 could be reasonably recommended to be treated as ACO, and additional laboratory testing would be recommended for patients with 1 and 2 points.http://www.sciencedirect.com/science/article/pii/S1323893023000059AsthmaAsthma-COPD overlapCOPDFeNOQuestionnaire
spellingShingle Yuki Suzuki
Hiroyuki Nagase
Hikaru Toyota
Sho Ohyatsu
Konomi Kobayashi
Yuri Takeshita
Yuuki Uehara
Saya Hattori
Mana Ishizuka
Hirokazu Sakasegawa
Michio Kuramochi
Tadashi Kohyama
Naoya Sugimoto
Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
Allergology International
Asthma
Asthma-COPD overlap
COPD
FeNO
Questionnaire
title Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
title_full Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
title_fullStr Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
title_full_unstemmed Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
title_short Questionnaire for diagnosing asthma-COPD overlap in COPD: Development of ACO screening questionnaire (ACO-Q)
title_sort questionnaire for diagnosing asthma copd overlap in copd development of aco screening questionnaire aco q
topic Asthma
Asthma-COPD overlap
COPD
FeNO
Questionnaire
url http://www.sciencedirect.com/science/article/pii/S1323893023000059
work_keys_str_mv AT yukisuzuki questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT hiroyukinagase questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT hikarutoyota questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT shoohyatsu questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT konomikobayashi questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT yuritakeshita questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT yuukiuehara questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT sayahattori questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT manaishizuka questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT hirokazusakasegawa questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT michiokuramochi questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT tadashikohyama questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq
AT naoyasugimoto questionnairefordiagnosingasthmacopdoverlapincopddevelopmentofacoscreeningquestionnaireacoq